Anmelden Kostenlos registrieren

T2 Biosystems Inc leerverkaufte Aktien zu allen Aktien

Was ist das leerverkaufte Aktien zu allen Aktien von T2 Biosystems Inc?

leerverkaufte Aktien zu allen Aktien von T2 Biosystems Inc ist 1.25

Was ist die Definition von leerverkaufte Aktien zu allen Aktien?



Das Leerverkauf-Verhältnis ist die Anzahl der leervekauften Aktien geteilt durch das durchschnittliche tägliche Volumen.

Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.

The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.

leerverkaufte Aktien zu allen Aktien von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu T2 Biosystems Inc

Was macht T2 Biosystems Inc?

t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www

Unternehmen mit leerverkaufte aktien zu allen aktien ähnlich T2 Biosystems Inc